Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology-Clinical Diagnosis: Solid Tumors

The role of the change of tumor metabolic volume (MV) for monitoring cancer therapy in 18F-FDG-PET/CT

Shigeki Nagamachi, Shogo Kiyohara, Hideyuki Wakamatsu, Seigo Fujita, Shigemi Futami, Shozo Tamura and Hideo Arita
Journal of Nuclear Medicine May 2008, 49 (supplement 1) 371P;
Shigeki Nagamachi
1Radiology, Miyazaki Medical College, Miyazaki-gun, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shogo Kiyohara
1Radiology, Miyazaki Medical College, Miyazaki-gun, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideyuki Wakamatsu
1Radiology, Miyazaki Medical College, Miyazaki-gun, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seigo Fujita
1Radiology, Miyazaki Medical College, Miyazaki-gun, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigemi Futami
1Radiology, Miyazaki Medical College, Miyazaki-gun, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shozo Tamura
1Radiology, Miyazaki Medical College, Miyazaki-gun, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideo Arita
1Radiology, Miyazaki Medical College, Miyazaki-gun, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 49 no. supplement 1 371P

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 3, 2014.

Copyright & Usage 
Society of Nuclear Medicine, Inc.

Author Information

  1. Shigeki Nagamachi1,
  2. Shogo Kiyohara1,
  3. Hideyuki Wakamatsu1,
  4. Seigo Fujita1,
  5. Shigemi Futami1,
  6. Shozo Tamura1 and
  7. Hideo Arita1
  1. 1Radiology, Miyazaki Medical College, Miyazaki-gun, Japan

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2015 to April 2025

AbstractFullPdf
May 2015100
Sep 2015500
Apr 2016300
Sep 2016100
Oct 2016200
Dec 2016300
Jan 2017200
Mar 2017600
Apr 2017100
Oct 2017300
Nov 20181900
Sep 2019100
Dec 2020100
Feb 2021700
Mar 20211600
Apr 20212400
May 20211900
Jun 20212100
Jul 20211000
Aug 20211600
Sep 2021100
Oct 2021100
Nov 20212900
Dec 2021900
Jan 2022200
Feb 2022300
Mar 2022300
May 2022100
Jun 2022200
Aug 2022100
Dec 2022100
Mar 2023200
Apr 2023100
May 2023100
Jun 2023100
Jul 2023100
Aug 2023100
Sep 2023300
Oct 2023100
Nov 2023500
Dec 2023500
Jan 2024300
Feb 2024200
Mar 2024300
Apr 20241100
May 2024500
Jun 2024100
Jul 2024200
Aug 2024200
Sep 2024600
Oct 2024200
Nov 2024300
Dec 2024400
Jan 2025100
Feb 2025100
Mar 2025200
Apr 2025600
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 49, Issue supplement 1
May 1, 2008
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The role of the change of tumor metabolic volume (MV) for monitoring cancer therapy in 18F-FDG-PET/CT
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The role of the change of tumor metabolic volume (MV) for monitoring cancer therapy in 18F-FDG-PET/CT
Shigeki Nagamachi, Shogo Kiyohara, Hideyuki Wakamatsu, Seigo Fujita, Shigemi Futami, Shozo Tamura, Hideo Arita
Journal of Nuclear Medicine May 2008, 49 (supplement 1) 371P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The role of the change of tumor metabolic volume (MV) for monitoring cancer therapy in 18F-FDG-PET/CT
Shigeki Nagamachi, Shogo Kiyohara, Hideyuki Wakamatsu, Seigo Fujita, Shigemi Futami, Shozo Tamura, Hideo Arita
Journal of Nuclear Medicine May 2008, 49 (supplement 1) 371P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology-Clinical Diagnosis: Solid Tumors

  • 15O-H2O-PET analysis of blood flow in esophageal cancer
  • Two weeks of single agent cetuximab (CET) induce a decrease in the tumor glucose-uptake measured by 18FDG-PET during neoadjuvant treatment of locally advanced squamous cell carcinoma (SCC) of the esophagus
  • Clinical impact of FDG-PET in the follow-up or suspicion of recurrent gastric cancer
Show more Oncology-Clinical Diagnosis: Solid Tumors

Clinical Diagnosis-Solid Tumors Posters

  • Can PET/CT predict complete response of esophageal cancer to chemo radiation therapy?
  • Results of 18F-FDG PET/CT and 68Ga-DOTA-TOC PET/CT correlate with tissue markers of poor prognosis in neuroendocrine tumors
  • Prediction of therapy outcome in patients with high risk soft tissue sarcomas (STS) using dynamic FDG follow-up studies
Show more Clinical Diagnosis-Solid Tumors Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire